B platform trial has been carefully constructed and maximized to reach efficacy and marketability. The failure of poly tarnished B. not to mention the relatively small amount paid for the portfolio. Leo and dr. M. Would not rush an insuperior product to market to end in failure. That would cause irreparable damage to future product lines and financing. I think this plan is a master stroke and will result in a waterfall of trial results, partnerships, BOD and up listing.
Market Data 
Markets 
AI
